PureTech Scientific supports glycolic acid as a biocidal active substance in the BPR review process, with PureTech Scientific International BV acting as its EU representative for Article 95 purposes.
This provides a documented regulatory basis for sourcing Glyclean® D for the supported Product Types, subject to applicable product and market requirements.
What Differentiates Glyclean® D in Supplier Selection?
Not every glycolic acid supplier necessarily provides the same regulatory support for biocidal applications. PureTech Scientific's participation in the BPR review programme and its Article 95 arrangements distinguish Glyclean® D from sources without an applicable Article 95-listed supplier.
For customers comparing glycolic acid sources, this creates three practical considerations:
The distinction is regulatory rather than a claim that Glyclean® D has superior chemical performance to competing glycolic acid products. Buyers should verify the relevant Article 95 supplier and Product Type coverage when comparing available sources.
Source Glyclean® D Through ChemPoint
For manufacturers and distributors supplying biocidal products in Europe, selecting an appropriately supported active substance source is an important step in regulatory compliance and purchasing decisions. ChemPoint supports customers evaluating PureTech Scientific Glyclean® D Glycolic Acid for biocidal Product Types 2, 3 and 4.
Talk to our experts to discuss Glyclean® D, confirm current Article 95 supplier status and product availability, or review sourcing requirements for your European biocidal application.